Identification of Noninvasive Biomarkers for Neonates Undergoing Abdominal Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05181423

Enrollment

2000

Registered

2022-01-06

Start date

2021-01-01

Completion date

2024-12-31

Last updated

2022-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarkers, Neonate

Brief summary

To identify the potential serum and radiological biomarkers with regard to neonates undergoing abdominal surgery, and to further evaluate the prognostic value of these markers.

Detailed description

First, the investigators will collect serum biomarkers in neonate patients receiving abdominal surgery. Then the investigators will identify the characteristics and change of biomarkers expressed in neonate patients before and after abdominal surgery. The investigators will further evaluate the prognostic value of these markers for neonate patients receiving abdominal surgery.

Interventions

OTHERBiomarkers

Different serum and radiological biomarkers neonates undergoing abdominal surgery.

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

0 Years to 18 Years

Inclusion criteria

* Age up to 18 years old * With written informed consent

Exclusion criteria

* Clinical data missing * Without written informed consent

Design outcomes

Primary

Measure	Time frame	Description
Value of non-invasive biomarkers	At least 5-year follow up	These markers will be collected in association with the prognostication for neonates before and after surgery.

Countries

China

Contacts

Primary ContactYuhan Yang, MD

yyh_1023@163.com8613258389785

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026